ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2257

Symptom Complexes At The Beginning Of Rheumatoid Arthritis: A Qualitative Exploration In At Risk Individuals and In New Patients Prior To Diagnosis

Rebecca J Stack1, Lilian H.D. van Tuyl2, Maurits Sloots3, Lotte A. van de Stadt3, Wijnanda Hoogland3, Bertha Matt3, Christian D Mallen4, Rumandeep Tiwana1, Karim Raza1 and Dirkjan van Schaardenburg3, 1Centre for Translational Inflammation Research, University of Birmingham, Birmingham, United Kingdom, 2Rheumatology, VU University Medical Center, Amsterdam, Netherlands, 3Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 4Arthritis Research UK Primary Care Centre, University of Keele, Keele, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Early Rheumatoid Arthritis, qualitative and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis-Clinical Aspects III: Outcome Measures, Socioeconomy, Screening, Biomarkers in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: To achieve better prediction of the development of rheumatoid arthritis (RA) a EULAR study group recommended identification and assessment of symptoms in those with arthralgia and during the earliest phases of clinical arthritis as a research priority.The aim of this study was to explore early symptom experiences in individuals with arthralgia at risk of RA and in individuals with new onset RA.

Methods: Focus groups with fifteen arthralgia patients (positive anti-CCP) and in-depth interviews with eleven newly presenting RA patients (2010 criteria) were conducted. An active feedback procedure was used to share experiences of arthralgia patients with early RA patients and vice versa. When saturation was reached transcripts were analysed using thematic analysis and major themes were identified. The analyses were merged to explore similarities and differences in themes between groups.

Results: Themes common to arthralgia and early RA patients included: pain (described in the joints and also in muscles and tendons); tingling sensations; loss of strength and weakness; fatigue and sleeping difficulties; self-reported swelling, redness and warmth; joint stiffness and intermittent symptoms. However, some differences were noted. Arthralgia patients described pain that was often concentrated in their hands and feet as bothersome and annoying. Early RA patients described pain that had intensified to excruciating levels before diagnosis; in some cases pain was likened to a broken bone. Arthralgia patients reported short episodes of intermittent swelling which often involved feelings of pain and fatigue. RA patients recalled that changes in their experience of swelling marked a significant change in the course of their illness, with the nature and pattern of swelling (such as intensification, development of symmetry, translocation) changing shortly before being diagnosed. Such changes were reported to be triggers for patient consultation and physician referral. Fatigue and sleeping difficulties were a dominant problem for arthralgia patients, they noted intense and troubling pain at night. RA patients also reported that night pain was one of the first symptoms they recalled. 

Conclusion: Understanding the features and patterns of symptoms characterising the earliest stages of RA is important if patients are to be identified and started on treatment early. Arthralgia and early RA patients shared symptoms which characterised the onset of disease, however, this detailed exploration of symptoms highlighted how the intensity (e.g. pain), and the pattern (e.g. changes in the pattern of swelling) differ between the two groups. Further research to develop measures of symptom patterns and clusters which occur in arthralgia patients and may signal the emergence of RA is required. This research should be followed by quantitative explorations of symptom clusters and their associated features.


Disclosure:

R. J. Stack,
None;

L. H. D. van Tuyl,
None;

M. Sloots,
None;

L. A. van de Stadt,
None;

W. Hoogland,
None;

B. Matt,
None;

C. D. Mallen,
None;

R. Tiwana,
None;

K. Raza,
None;

D. van Schaardenburg,

Patent,

4.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/symptom-complexes-at-the-beginning-of-rheumatoid-arthritis-a-qualitative-exploration-in-at-risk-individuals-and-in-new-patients-prior-to-diagnosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology